Your browser doesn't support javascript.
loading
Comparison of myeloid neoplasms with nonclassic 3q26.2/MECOM versus classic inv(3)/t(3;3) rearrangements reveals diverse clinicopathologic features, genetic profiles, and molecular mechanisms of MECOM activation.
Gao, Juehua; Gurbuxani, Sandeep; Zak, Taylor; Kocherginsky, Masha; Ji, Peng; Wehbe, Firas; Chen, Qing; Chen, Yi-Hua; Lu, Xinyan; Jennings, Lawrence; Frankfurt, Olga; Altman, Jessica; Sukhanova, Madina.
Afiliação
  • Gao J; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Gurbuxani S; Department of Pathology, University of Chicago, Chicago, Illinois, USA.
  • Zak T; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Kocherginsky M; Department of Preventive Medicine (Health and Biomedical Informatics), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Ji P; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Wehbe F; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Chen Q; Department of Preventive Medicine (Health and Biomedical Informatics), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Chen YH; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Lu X; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Jennings L; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Frankfurt O; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Altman J; Department of Hematology and Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Sukhanova M; Department of Hematology and Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Genes Chromosomes Cancer ; 61(2): 71-80, 2022 02.
Article em En | MEDLINE | ID: mdl-34668265
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Rearranjo Gênico / Leucemia Mieloide / Proteína do Locus do Complexo MDS1 e EVI1 Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Genes Chromosomes Cancer Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Rearranjo Gênico / Leucemia Mieloide / Proteína do Locus do Complexo MDS1 e EVI1 Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Genes Chromosomes Cancer Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos